VASANTA KUSUMAKARA RASA: A MICRONUTRIENT-RICH RASAYANA FORMULTI-PRONGED DIABETES MANAGEMENT

Aims and Objectives: To explore the therapeutic potential of Vasanta kusumakara Rasa (VKR), a classical Ayurvedic herbo-mineral formulation, in the management of metabolic disorders, especially diabetes mellitus. The objective is to assess VKR’s mechanism of action beyond conventional hypoglycemic effects and reposition it as a metabolic enhancer based on modern pharmacological insights. Materials and Methods: This is a nar-rative review that synthesizes classical Ayurvedic references, pharmacognostic analyses, and recent biomedi-cal studies. Sources include Ayurvedic compendia and peer-reviewed literature examining VKR's pharmacody-namic properties, particularly its effects on oxidative stress, lipid metabolism, and micronutrient regulation. Dis-cussion: Traditionally classified as Pramehaghna (anti-diabetic), VKR is rich in metals and minerals like gold, silver, calcium, and iron, which demonstrate antioxidants, immunomodulatory, and neuroprotective effects. Cur-rent evidence indicates that VKR does not act solely as a glucose-lowering agent. Instead, it improves systemic metabolic functions by correcting underlying imbalances. This repositioning highlights its role in modulating oxidative stress and restoring micronutrient homeostasis, thereby supporting broader metabolic regulation. VKR’s adaptogenic and rejuvenative actions align with its classical designation as a Rasayana, making it suita-ble for long-term use, including in prediabetic states and diabetic complications. Conclusion: VKR should be considered a metabolic enhancer rather than a direct hypoglycemic drug. This expanded understanding supports its use as an adjuvant therapy in diabetes care and calls for further clinical studies to validate its integrative role in treating multipronged diabetes.

Authors

Publication Details

Journal
International Ayurvedic Medical Journal
Published
2025-08-13
DOI
https://doi.org/10.46607/iamj3213082025
Primary Topic
Phytochemicals and Medicinal Plants
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

VASANTA KUSUMAKARA RASA: A MICRONUTRIENT-RICH RASAYANA FORMULTI-PRONGED DIABETES MANAGEMENT

Saranya B Sasi, S. S. Kadam, Shital Nathgosavi
International Ayurvedic Medical Journal
Phytochemicals and Medicinal Plants
article

VASANTA KUSUMAKARA RASA: A MICRONUTRIENT-RICH RASAYANA FORMULTI-PRONGED DIABETES MANAGEMENT

Saranya B Sasi, S. S. Kadam, Shital Nathgosavi
article en

Abstract

Aims and Objectives: To explore the therapeutic potential of Vasanta kusumakara Rasa (VKR), a classical Ayurvedic herbo-mineral formulation, in the management of metabolic disorders, especially diabetes mellitus. The objective is to assess VKR’s mechanism of action beyond conventional hypoglycemic effects and reposition it as a metabolic enhancer based on modern pharmacological insights. Materials and Methods: This is a nar-rative review that synthesizes classical Ayurvedic references, pharmacognostic analyses, and recent biomedi-cal studies. Sources include Ayurvedic compendia and peer-reviewed literature examining VKR's pharmacody-namic properties, particularly its effects on oxidative stress, lipid metabolism, and micronutrient regulation. Dis-cussion: Traditionally classified as Pramehaghna (anti-diabetic), VKR is rich in metals and minerals like gold, silver, calcium, and iron, which demonstrate antioxidants, immunomodulatory, and neuroprotective effects. Cur-rent evidence indicates that VKR does not act solely as a glucose-lowering agent. Instead, it improves systemic metabolic functions by correcting underlying imbalances. This repositioning highlights its role in modulating oxidative stress and restoring micronutrient homeostasis, thereby supporting broader metabolic regulation. VKR’s adaptogenic and rejuvenative actions align with its classical designation as a Rasayana, making it suita-ble for long-term use, including in prediabetic states and diabetic complications. Conclusion: VKR should be considered a metabolic enhancer rather than a direct hypoglycemic drug. This expanded understanding supports its use as an adjuvant therapy in diabetes care and calls for further clinical studies to validate its integrative role in treating multipronged diabetes.

International Ayurvedic Medical JournalVol. 13(08)
Openalex Percentile: Top 57%
Phytochemicals and Medicinal Plants
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.